Citations (95)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Nanna N. Kristensen, Esben G. W. Schmidt, Susanne Rasmussen, Emilie Balk-Møller & Mogens H. Claesson. (2013) B7-H4-Ig treatment of normal mice changes lymphocyte homeostasis and increases the potential of regulatory T cells. Immunopharmacology and Immunotoxicology 35:4, pages 505-513.
Read now
Read now
Adalberto Parra, Jorge Ramírez-Peredo, Enrique Reyes, Rocío Hidalgo, Julio Macías-Gallardo, Julia Lutz-Presno, Alejandro Ruiz-Argüelles, Eduardo Garza, Eduardo Infante, César H. Gutiérrez-Aguirre, Rosario Salazar-Riojas, Jesús Z. Villarreal, David Gómez-Almaguer & Guillermo J. Ruiz-Argüelles. (2012) Moderate hyperprolactinemia is associated with survival in patients with acute graft-versus-host disease after allogeneic stem cell transplantation. Hematology 17:2, pages 85-92.
Read now
Read now
Guro Kristin Melve, Elisabeth Ersvær, Astrid Olsnes Kittang & Øystein Bruserud. (2011) The chemokine system in allogeneic stem-cell transplantation: a possible therapeutic target?. Expert Review of Hematology 4:5, pages 563-576.
Read now
Read now
John Koreth & Joseph H Antin. (2008) Current and future approaches for control of graft-versus-host disease. Expert Review of Hematology 1:1, pages 111-128.
Read now
Read now
Wolfgang Hinterberger & Margareta Hinterberger-Fischer. (2001) Blood stem cell transplantation for breast cancer: new approaches using pre- peri- post-transplant immunotherapy. Expert Opinion on Biological Therapy 1:6, pages 1029-1048.
Read now
Read now
Articles from other publishers (90)
Rabab Ali Al Attas, Razan M. Bader, Miral Mashhour, Zuhoor A. AlQahtani, Amani Mohammed, Masood Qahtani, Zahid B. Arain, Nadya Faraidy, Mohammad Awaji, Gamil Mohammed, Hassan A. Alharbi, Mariam AlZahrani, Amal Aqool & Ghandorah Salim. (2021) Graft‐versus‐host disease after pediatric liver transplantation: A diagnostic challenge. Pediatric Transplantation 26:3.
Crossref
Crossref
Viviane A. Agbogan, Pauline Gastineau, Emmanuel Tejerina, Saoussen Karray & Flora Zavala. (2022) CpG-Activated Regulatory B-Cell Progenitors Alleviate Murine Graft-Versus-Host-Disease. Frontiers in Immunology 13.
Crossref
Crossref
Christelle Piperoglou, Guillaume Larid, Blandine Vallentin, Laura Balligand, Adeline Crinier, Nathalie Banzet, Catherine Farnarier, Elena Gomez-Massa, Aranzazu Cruz Adalia, Gérard Michel, Claire Galambrun, Vincent Barlogis, Eric Vivier & Frédéric Vély. (2022) Innate lymphoid cell recovery and occurrence of GvHD after hematopoietic stem cell transplantation. Journal of Leukocyte Biology 111:1, pages 161-172.
Crossref
Crossref
Lijuan Ding, Yiyun Wang, Ruimin Hong, Houli Zhao, Linghui Zhou, Guoqing Wei, Wenjun Wu, Huijun Xu, Yanlei Zhang, Yi Luo, Jimin Shi, Alex H. Chang, Yongxian Hu & He Huang. (2021) Efficacy and Safety of Chimeric Antigen Receptor T Cells in Acute Lymphoblastic Leukemia With Post-Transplant Relapse. Frontiers in Oncology 11.
Crossref
Crossref
G. de Jong, M.A. Gillissen, H. Spits & M.D. Hazenberg. (2020) Tumour-reactive B cells and antibody responses after allogeneic haematopoietic cell transplantation. Immuno-Oncology Technology 7, pages 15-22.
Crossref
Crossref
Alice Garnier, Thierry Guillaume, Pierre Peterlin, Amandine Le Bourgeois, Béatrice Mahé, Viviane Dubruille, Nicolas Blin, Cyrille Touzeau, Thomas Gastinne, Anne Lok, Benoit Tessoulin, Alix Duquesne, Marion Eveillard, Steven Le Gouill, Philippe Moreau, Marie C. Béné & Patrice Chevallier. (2020) Absence of influence of peripheral blood CD34+ and CD3+ graft cell counts on outcomes after reduced-intensity conditioning transplantation using post-transplant cyclophosphamide. Annals of Hematology 99:6, pages 1341-1350.
Crossref
Crossref
Mohammad Fereidouni, Afshin Derakhshani & Mark A. Exley. (2019) iNKT cells and hematopoietic stem cell transplantation: Two-phase activation of iNKT cells may improve outcome. Clinical Immunology 207, pages 43-48.
Crossref
Crossref
Christian Koenecke & Andreas Krueger. (2018) MicroRNA in T-Cell Development and T-Cell Mediated Acute Graft-Versus-Host Disease. Frontiers in Immunology 9.
Crossref
Crossref
Rumi Ishii, Toshihito Hirai, Satoshi Miyairi, Kazuya Omoto, Masayoshi Okumi, Yasuyuki Ishii & Kazunari Tanabe. (2018) iNKT cell activation plus T-cell transfer establishes complete chimerism in a murine sublethal bone marrow transplant model. American Journal of Transplantation 18:2, pages 328-340.
Crossref
Crossref
Federica Cattina, Simona Bernardi, Vilma Mantovani, Eleonora Toffoletti, Alessandra Santoro, Domenico Pastore, Bruno Martino, Giuseppe Console, Giovanni Martinelli & Michele Malagola. (2017) Single Step Multiple Genotyping by MALDI-TOF Mass Spectrometry, for Evaluation of Minor Histocompatibility Antigens in Patients Submitted to Allogeneic Stem Cell Transplantation from HLA-Matched Related and Unrelated Donor. Hematology Reports 9:3, pages 7051.
Crossref
Crossref
N Kawashima, S Terakura, S Nishiwaki, D Koyama, Y Ozawa, M Ito & K Miyamura. (2017) Increase of bone marrow macrophages and CD8+ T lymphocytes predict graft failure after allogeneic bone marrow or cord blood transplantation. Bone Marrow Transplantation 52:8, pages 1164-1170.
Crossref
Crossref
Charles S. Via, Kateryna Soloviova, Maksym Puliaiev, Roman Puliav, Irina Puliaeva, Suzanne C. Morris & Fred D. Finkelman. (2017) In vivo IL-4 prevents allo-antigen driven CD8+ CTL development. Clinical Immunology 180, pages 11-24.
Crossref
Crossref
Takeshi Sugio, Koji Kato, Takatoshi Aoki, Takanori Ohta, Noriyuki Saito, Shuro Yoshida, Ichiro Kawano, Hideho Henzan, Masanori Kadowaki, Ken Takase, Tsuyoshi Muta, Kohta Miyawaki, Takuji Yamauchi, Takahiro Shima, Shuichiro Takashima, Yasuo Mori, Goichi Yoshimoto, Kenjiro Kamezaki, Katsuto Takenaka, Hiromi Iwasaki, Ryosuke Ogawa, Yuju Ohno, Tetsuya Eto, Tomohiko Kamimura, Toshihiro Miyamoto & Koichi Akashi. (2016) Mogamulizumab Treatment Prior to Allogeneic Hematopoietic Stem Cell Transplantation Induces Severe Acute Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation 22:9, pages 1608-1614.
Crossref
Crossref
Qiu-ling Wu, Xiao-yun Liu, Di-min Nie, Xia-xia Zhu, Jun Fang, Yong You, Zhao-dong Zhong, Ling-hui Xia & Mei Hong. (2015) Umbilical cord blood-derived mesenchymal stem cells ameliorate graft-versus-host disease following allogeneic hematopoietic stem cell transplantation through multiple immunoregulations. Journal of Huazhong University of Science and Technology [Medical Sciences] 35:4, pages 477-484.
Crossref
Crossref
Nancy Y. VillaClive H. Wasserfall, Amy M. MeachamElizabeth WiseWinnie Chan, John R. WingardGrant McFadden & Christopher R. Cogle. (2015) Myxoma virus suppresses proliferation of activated T lymphocytes yet permits oncolytic virus transfer to cancer cells. Blood 125:24, pages 3778-3788.
Crossref
Crossref
Melissa Weiss, Daniel Steinbach, Felix Zintl, James Beck & Bernd Gruhn. (2014) Superior outcome using cyclosporin A alone versus cyclosporin A plus methotrexate for post-transplant immunosuppression in children with acute leukemia undergoing sibling hematopoietic stem cell transplantation. Journal of Cancer Research and Clinical Oncology 141:6, pages 1089-1094.
Crossref
Crossref
Lucie Leveque, Laetitia Le Texier, Katie E Lineburg, Geoffrey R Hill & Kelli PA MacDonald. (2014) Autophagy and haematopoietic stem cell transplantation. Immunology & Cell Biology 93:1, pages 43-50.
Crossref
Crossref
Jianing Fu, Jessica Heinrichs & Xue-Zhong Yu. (2014) Helper T-Cell Differentiation in Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation. Archivum Immunologiae et Therapiae Experimentalis 62:4, pages 277-301.
Crossref
Crossref
Amandine Le Bourgeois, Elsa Lestang, Thierry Guillaume, Jacques Delaunay, Sameh Ayari, Nicolas Blin, Aline Clavert, Benoit Tessoulin, Viviane Dubruille, Beatrice Mahe, Virginie Roland, Thomas Gastinne, Steven Le Gouill, Philippe Moreau, Mohamad Mohty, Lucie Planche & Patrice Chevallier. (2013)
Prognostic impact of immune status and hematopoietic recovery before and after fludarabine,
IV
busulfan, and antithymocyte globulins (
FB
2 regimen) reduced‐intensity conditioning regimen (
RIC
) allogeneic stem cell transplantation (allo‐
SCT
)
. European Journal of Haematology 90:3, pages 177-186.
Crossref
Crossref
Jian ZhengYinping LiuYuan LiuMing LiuZheng XiangKwok-Tai LamDavid B. LewisYu-Lung LauWenwei Tu. (2013)
Human CD8
+
Regulatory T Cells Inhibit GVHD and Preserve General Immunity in Humanized Mice
. Science Translational Medicine 5:168.
Crossref
Crossref
Bruce R. Blazar, William J. Murphy & Mehrdad Abedi. (2012) Advances in graft-versus-host disease biology and therapy. Nature Reviews Immunology 12:6, pages 443-458.
Crossref
Crossref
James L. M. Ferrara & Pavan Reddy. 2012. Advances in Stem Cell Research. Advances in Stem Cell Research
303
366
.
Yu YuDapeng WangChen Liu, Kane KaosaardKenrick Semple, Claudio Anasetti & Xue-Zhong Yu. (2011) Prevention of GVHD while sparing GVL effect by targeting Th1 and Th17 transcription factor T-bet and RORγt in mice. Blood 118:18, pages 5011-5020.
Crossref
Crossref
Nancy M. Hardy, Miriam E. Mossoba, Seth M. Steinberg, Vicki Fellowes, Xiao-Yi Yan, Frances T. Hakim, Rebecca R. Babb, Daniele Avila, Juan Gea-Banacloche, Claude Sportès, Bruce L. Levine, Carl H. June, Hahn M. Khuu, Ashley E. Carpenter, Michael C. Krumlauf, Andrew J. Dwyer, Ronald E. Gress, Daniel H. Fowler & Michael R. Bishop. (2011) Phase I Trial of Adoptive Cell Transfer with Mixed-Profile Type-I/Type-II Allogeneic T Cells for Metastatic Breast Cancer. Clinical Cancer Research 17:21, pages 6878-6887.
Crossref
Crossref
Sung Choi & Pavan Reddy. (2011) HDAC Inhibition and Graft Versus Host Disease. Molecular Medicine 17:5-6, pages 404-416.
Crossref
Crossref
A Alsultan, R H Giller, D Gao, J Bathurst, E Hild, L Gore, N K Foreman, A Keating & R R Quinones. (2010) GVHD after unrelated cord blood transplant in children: characteristics, severity, risk factors and influence on outcome. Bone Marrow Transplantation 46:5, pages 668-675.
Crossref
Crossref
Wei Sang, Cui Zhou, Nana Cheng, Zhengyu Li, Lingyu Zeng & Kailin Xu. (2011) Control of mouse graft-versus-host disease following allogeneic bone marrow transplantation by blocking the CD28/B7 signaling pathway with lentiviral vector-mediated RNA interference. Immunology Letters 136:2, pages 194-202.
Crossref
Crossref
David L. Porter, Edwin P. Alyea, Joseph H. Antin, Marcos DeLima, Eli Estey, J.H. Frederik Falkenburg, Nancy Hardy, Nicolaus Kroeger, Jose Leis, John Levine, David G. Maloney, Karl Peggs, Jacob M. Rowe, Alan S. Wayne, Sergio Giralt, Michael R. Bishop & Koen van Besien. (2010) NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation 16:11, pages 1467-1503.
Crossref
Crossref
S Paczesny, D Hanauer, Y Sun & P Reddy. (2009) New perspectives on the biology of acute GVHD. Bone Marrow Transplantation 45:1, pages 1-11.
Crossref
Crossref
Nicolai A. Kittan & Gerhard C. Hildebrandt. 2010. The Chemokine System in Experimental and Clinical Hematology. The Chemokine System in Experimental and Clinical Hematology
97
120
.
John Koreth, Edwin P. Alyea, William J. Murphy & Lisbeth A. Welniak. (2009) Proteasome Inhibition and Allogeneic Hematopoietic Stem Cell Transplantation: A Review. Biology of Blood and Marrow Transplantation 15:12, pages 1502-1512.
Crossref
Crossref
Jian-Ming LiCynthia R GiverYing LuMohammad S HossainMojtaba AkhtariEdmund K Waller. (2009) Separating graft-versus-leukemia from graft-versus-host disease in allogeneic hematopoietic stem cell transplantation. Immunotherapy 1:4, pages 599-621.
Crossref
Crossref
Alan S. Wayne. (2009) Application of immunotherapy in pediatric leukemia. Current Hematologic Malignancy Reports 4:3, pages 159-166.
Crossref
Crossref
D. Hauzenberger, M. Schaffer, O. Ringdén, Z. Hassan, B. Omazic, J. Mattsson, A.-C. Wikström & M. Remberger. (2008)
Outcome of haematopoietic stem cell transplantation in patients transplanted with matched unrelated donors
vs
allele-mismatched donors: a single centre study
. Tissue Antigens 72:6, pages 549-558.
Crossref
Crossref
Thea M. Friedman, Kira GoldgirshStephanie A. BergerJenny ZilberbergJoanne Filicko-O'Hara, Neal Flomenberg, Michele DonatoScott D. RowleyRobert Korngold. (2008) Overlap between in vitro donor antihost and in vivo posttransplantation TCR Vβ use: a new paradigm for designer allogeneic blood and marrow transplantation. Blood 112:8, pages 3517-3525.
Crossref
Crossref
Yihong Huang, Bing Du, Kailin Xu, Depeng Li, Xupeng He, Qunxian Lu & Xiuying Pan. (2008) Induction of graft-versus-leukemia effect using a mixture of syngeneic plus G-CSF primed haploidentical bone marrow grafts in mice. The Chinese-German Journal of Clinical Oncology 7:9, pages 549-554.
Crossref
Crossref
Tomomi Toubai, Yaping Sun & Pavan Reddy. (2008) GVHD pathophysiology: is acute different from chronic?. Best Practice & Research Clinical Haematology 21:2, pages 101-117.
Crossref
Crossref
Pavan Reddy & James L. M. Ferrara. 2008. Hematopoietic Stem Cell Transplantation. Hematopoietic Stem Cell Transplantation
563
588
.
Yaping Sun, Isao Tawara, Tomomi Toubai & Pavan Reddy. (2007) Pathophysiology of acute graft-versus-host disease: recent advances. Translational Research 150:4, pages 197-214.
Crossref
Crossref
Shoshana Morecki, Elena Yacovlev, Yael Gelfand, Osnat Eizik & Shimon Slavin. (2007) Pretransplant treatment of donors with immunomodulators to control graft-versus-host disease (GVHD) in transplant recipients. Experimental Hematology 35:5, pages 748-756.
Crossref
Crossref
M. Lupu & R. Storb. (2007) Five decades of progress in haematopoietic cell transplantation based on the preclinical canine model. Veterinary and Comparative Oncology 5:1, pages 14-30.
Crossref
Crossref
Paul R. Sanberg, Denis K. English, Amal Hakki, Don F. Cameron, Svitlana Garbuzova-Davis, Alison E. Willing, Cesario V. Borlongan, Robert Henning, Stephen K. Klasko & Nagwa S. El-Badri. 2007. Cellular Transplantation. Cellular Transplantation
547
566
.
J Mattsson, S Westin, S Edlund & M Remberger. (2006) Poor oral nutrition after allogeneic stem cell transplantation correlates significantly with severe graft-versus-host disease. Bone Marrow Transplantation 38:9, pages 629-633.
Crossref
Crossref
Yair Reisner, Reich-Zeliger Shlomit & Esther Bachar-Lustig. (2006) The role of veto cells in bone marrow transplantation. Current Opinion in Organ Transplantation 11:4, pages 366-372.
Crossref
Crossref
Jian-Ming Li, Cynthia R. Giver & Edmund K. Waller. (2006) Graft engineering using ex vivo methods to limit GVHD: Fludarabine treatment generates superior GVL effects in allogeneic BMT. Experimental Hematology 34:7, pages 895-904.
Crossref
Crossref
Nancy M. Hardy, Daniel H. Fowler & Michael R. Bishop. (2006) Immunotherapy of Metastatic Breast Cancer: Phase I Trial of Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation with Th2/Tc2 T-Cell Exchange. Clinical Breast Cancer 7:1, pages 87-89.
Crossref
Crossref
Mojgan Shaiegan, Masoud Iravani, Gholam Reza Babaee & Ardeshir Ghavamzadeh. (2006) Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients. Transplant Immunology 15:3, pages 223-227.
Crossref
Crossref
Kouhei Yamashita, Mitchell E. Horwitz, Akua Kwatemaa, Effie Nomicos, Kathleen Castro, Robert Sokolic, Susan F. Foster, Mary Garofalo, Uimook Choi, Mark Ryherd, Margaret R. Brown, Susan F. Leitman, Alan S. Wayne, Daniel H. Fowler, Michael R. Bishop, Richard W. Childs, A. John Barrett, Steven Z. Pavletic & Harry L. Malech. (2006) Unique Abnormalities of CD4+ and CD8+ Central Memory Cells Associated with Chronic Graft-versus-Host Disease Improve after Extracorporeal Photopheresis. Biology of Blood and Marrow Transplantation 12:1, pages 22-30.
Crossref
Crossref
L T van der Veken, M Hoogeboom, R A de Paus, R Willemze, J H F Falkenburg & M H M Heemskerk. (2005) HLA class II restricted T-cell receptor gene transfer generates CD4+ T cells with helper activity as well as cytotoxic capacity. Gene Therapy 12:23, pages 1686-1695.
Crossref
Crossref
Ichiro Ohmori, Keisuke Hayamizu, Koichi Oishi, Masanori Yoshimitsu, Toshiyuki Itamoto & Toshimasa Asahara. (2005) Inhibition of tumor growth in immunocompromised hosts by restoring type-2 immunity using infusion of G-CSF-treated allogeneic CD8+ leukocytes. Cytokine 32:6, pages 255-262.
Crossref
Crossref
Kyoko Haraguchi, Tsuyoshi Takahashi, Akihiko Matsumoto, Takashi Asai, Yoshinobu Kanda, Mineo Kurokawa, Seishi Ogawa, Hideaki Oda, Masaru Taniguchi, Hisamaru Hirai & Shigeru Chiba. (2005) Host-Residual Invariant NK T Cells Attenuate Graft-versus-Host Immunity. The Journal of Immunology 175:2, pages 1320-1328.
Crossref
Crossref
Prakash Satwani, Janet Ayello, Carmella Ven, Allison F. O'Neill, Lynn L. Simpson, Laxmi Baxi & Mitchell S. Cairo. (2005) Immaturity of IL-18 gene expression and protein production in cord blood (CB) versus peripheral blood (PB) mononuclear cells and differential effects in natural killer (NK) cell development and function*. British Journal of Haematology 130:2, pages 284-292.
Crossref
Crossref
D L Porter & C H June. (2005) T-cell reconstitution and expansion after hematopoietic stem cell transplantation: ‘T’ it up!. Bone Marrow Transplantation 35:10, pages 935-942.
Crossref
Crossref
Noriko Kodama, Yukihito Murata, Akihiro Asakawa, Akio Inui, Masahiko Hayashi, Norio Sakai & Hiroaki Nanba. (2005) Maitake D-Fraction enhances antitumor effects and reduces immunosuppression by mitomycin-C in tumor-bearing mice. Nutrition 21:5, pages 624-629.
Crossref
Crossref
Shinichiro Yada, Noriaki Takamura, Kyoko Inagaki-Ohara, Melissa K. O’Leary, Christoph Wasem, Thomas Brunner, Douglas R. Green, Tesu Lin & Michael J. Pinkoski. (2005) The Role of p53 and Fas in a Model of Acute Murine Graft-versus-Host Disease. The Journal of Immunology 174:3, pages 1291-1297.
Crossref
Crossref
Daigo Hashimoto, Shoji Asakura, Sachiko Miyake, Takashi Yamamura, Luc Van Kaer, Chen Liu, Mitsune Tanimoto & Takanori Teshima. (2005) Stimulation of Host NKT Cells by Synthetic Glycolipid Regulates Acute Graft-versus-Host Disease by Inducing Th2 Polarization of Donor T Cells. The Journal of Immunology 174:1, pages 551-556.
Crossref
Crossref
Jeng-Chang Chen, Ming-Ling Chang, Hanmin Lee & Marcus O. Muench. (2005) Prevention of Graft Rejection by Donor Type II CD8<sup>+</sup> T Cells (Tc2 Cells) Is Not Sufficient to Improve Engraftment in Fetal Transplantation. Fetal Diagnosis and Therapy 20:1, pages 35-43.
Crossref
Crossref
Robert Soiffer. 2004. Graft vs. Host Disease, Third Edition. Graft vs. Host Disease, Third Edition
481
509
.
Libose Tauchmanovà, Giuseppe Matarese, Carlo Carella, Gennaro De Rosa, Bianca Serio, Patrizia Ricci, Gaetano Lombardi, Bruno Rotoli, Annamaria Colao & Carmine Selleri. (2004) High Serum Leptin in Patients with Chronic Graft-Versus-Host Disease after Hematopoietic Stem Cell Transplantation. Transplantation 78:9, pages 1376-1383.
Crossref
Crossref
Robert L. Truitt. (2004) The Mortimer M. Bortin lecture. Biology of Blood and Marrow Transplantation 10:8, pages 505-523.
Crossref
Crossref
Robert M. Dean & Michael R. Bishop. (2004) Allogeneic Hematopoietic Stem Cell Transplantation for Lymphoma. Clinical Lymphoma 4:4, pages 238-249.
Crossref
Crossref
Hongfeng Guo, Zhenhua Qiao, Lei Zhu, Hongwei Wang, Liping Su, Yujin Lu, Yuee Cui, Bo Jiang, Qioujuan Zhu & Lianrong Xu. (2004) Th1/Th2 cytokine profiles and their relationship to clinical features in patients following nonmyeloablative allogeneic stem cell transplantation. American Journal of Hematology 75:2, pages 78-83.
Crossref
Crossref
Pierre A Henkart & Marta Catalfamo. 2004. T Cell Subsets: Cellular Selection, Commitment and Identity. T Cell Subsets: Cellular Selection, Commitment and Identity
233
252
.
Vincent Ho & Robert J. Soiffer. 2004. Stem Cell Transplantation for Hematologic Malignancies. Stem Cell Transplantation for Hematologic Malignancies
431
451
.
S. M. Breathnach & M. M. Black. 2004. Rook's Textbook of Dermatology. Rook's Textbook of Dermatology
2089
2120
.
Pavan Reddy & James L.M Ferrara. (2003) Immunobiology of acute graft-versus-host disease. Blood Reviews 17:4, pages 187-194.
Crossref
Crossref
Pavan Reddy. (2003) Pathophysiology of acute graft‐versus‐host disease. Hematological Oncology 21:4, pages 149-161.
Crossref
Crossref
Arun R. Rao, Marlon P. Quinones, Edgar Garavito, Yogeshwar Kalkonde, Fabio Jimenez, Caroline Gibbons, Jennifer Perez, Peter Melby, William Kuziel, Robert L. Reddick, Sunil K. Ahuja & Seema S. Ahuja. (2003) CC Chemokine Receptor 2 Expression in Donor Cells Serves an Essential Role in Graft-versus-Host-Disease. The Journal of Immunology 171:9, pages 4875-4885.
Crossref
Crossref
Eric G. Jacquet, Carrie L. Schanie, Isabelle Fugier-Vivier, Sharon S. Willer & Suzanne T. Ildstad. (2003) Facilitating cells as a venue to establish mixed chimerism and tolerance. Pediatric Transplantation 7:5, pages 348-357.
Crossref
Crossref
Cynthia R Giver, Richard O Montes, Stephen Mittelstaedt, Jian-Ming Li, David L Jaye, Sagar Lonial, Michael W Boyer & Edmund K Waller. (2003) Ex vivo fludarabine exposure inhibits graft-versus-host activity of allogeneic T cells while preserving graft-versus-leukemia effects. Biology of Blood and Marrow Transplantation 9:10, pages 616-632.
Crossref
Crossref
Masahiro Imamura & Junji Tanaka. (2003) Immunoregulatory Cells for Transplantation Tolerance and Graft-versus-Leukemia Effect. International Journal of Hematology 78:3, pages 188-194.
Crossref
Crossref
J.H.Frederik Falkenburg, Lisette van de Corput, Erik W.A Marijt & Roel Willemze. (2003) Minor histocompatibility antigens in human stem cell transplantation. Experimental Hematology 31:9, pages 743-751.
Crossref
Crossref
Francine M. Foss. (2016) Extracorporeal Photopheresis in the Treatment of Graft-vs-Host Disease. Journal of Cutaneous Medicine and Surgery 7:4_suppl, pages 13-17.
Crossref
Crossref
C Rosenfeld, M A Cheever & A Gaiger. (2003) WT1 in acute leukemia, chronic myelogenous leukemia and myelodysplastic syndrome: therapeutic potential of WT1 targeted therapies. Leukemia 17:7, pages 1301-1312.
Crossref
Crossref
Margot Zöller. (2016) Immunotherapy of Cancer by Active Vaccination: Does Allogeneic Bone Marrow Transplantation after Non-Myeloablative Conditioning Provide a New Option?. Technology in Cancer Research & Treatment 2:3, pages 237-260.
Crossref
Crossref
Pavan ReddyTakanori TeshimaGerhard HildebrandtDebra L. WilliamsChen LiuKenneth R. CookeJames L.M. Ferrara. (2003) Pretreatment of donors with interleukin-18 attenuates acute graft-versus-host disease via STAT6 and preserves graft-versus-leukemia effects. Blood 101:7, pages 2877-2885.
Crossref
Crossref
Shawn M. RigbyTodd RouseElizabeth H. Field. (2003) Total lymphoid irradiation nonmyeloablative preconditioning enriches for IL-4–producing CD4+-TNK cells and skews differentiation of immunocompetent donor CD4+cells. Blood 101:5, pages 2024-2032.
Crossref
Crossref
Å Gustafsson Jernberg, M Remberger, O Ringdén & J Winiarski. (2003) Graft-versus-leukaemia effect in children: chronic GVHD has a significant impact on relapse and survival. Bone Marrow Transplantation 31:3, pages 175-181.
Crossref
Crossref
H. Joachim Deeg. (2003) New Strategies for Prevention and Treatment of Graft-versus-Host Disease and for Induction of Graft-versus-Leukemia Effects. International Journal of Hematology 77:1, pages 15-21.
Crossref
Crossref
Ginna G. Laport & Carl H. June. 2003. Allogeneic Stem Cell Transplantation. Allogeneic Stem Cell Transplantation
273
286
.
Søren Lykke Petersen, Charlotte Astrid Russell, Klaus Bendtzen & Lars Lindhardt Vindeløv. (2002) Optimisation of the CT.h4S bioassay for detection of human interleukin-4 secreted by mononuclear cells stimulated by phytohaemaglutinin or by human leukocyte antigen mismatched mixed lymphocyte culture. Immunology Letters 84:1, pages 29-39.
Crossref
Crossref
Gullu GorgunKenneth B. MillerFrancine M. Foss. (2002) Immunologic mechanisms of extracorporeal photochemotherapy in chronic graft-versus-host disease. Blood 100:3, pages 941-947.
Crossref
Crossref
Martin GuimondAntonia BalassyMélanie BarretteSylvie BrochuClaude PerreaultDenis Claude Roy. (2002) P-glycoprotein targeting: a unique strategy to selectively eliminate immunoreactive T cells. Blood 100:2, pages 375-382.
Crossref
Crossref
FM Foss, G Gorgun & KB Miller. (2002) Extracorporeal photopheresis in chronic graft-versus-host disease. Bone Marrow Transplantation 29:9, pages 719-725.
Crossref
Crossref
Marie-Térèse Little & Rainer Storb. (2002) History of haematopoietic stem-cell transplantation. Nature Reviews Cancer 2:3, pages 231-238.
Crossref
Crossref
Takanori Teshima & James L.M. Ferrara. (2002) Understanding the alloresponse: New approaches to graft-versus-host disease prevention. Seminars in Hematology 39:1, pages 15-22.
Crossref
Crossref
Pavan Reddy, Takanori Teshima, Mark Kukuruga, Rainer Ordemann, Chen Liu, Kathy Lowler & James L.M. Ferrara. (2001) Interleukin-18 Regulates Acute Graft-Versus-Host Disease by Enhancing Fas-mediated Donor T Cell Apoptosis. The Journal of Experimental Medicine 194:10, pages 1433-1440.
Crossref
Crossref
Michael W. Delfs, Yutaka Furukawa, Richard N. Mitchell & Andrew H. Lichtman. (2001) CD8+ T CELL SUBSETS TC1 AND TC2 CAUSE DIFFERENT HISTOPATHOLOGIC FORMS OF MURINE CARDIAC ALLOGRAFT REJECTION1. Transplantation 71:5, pages 606-610.
Crossref
Crossref
Roger D. Dansey & Roy D. Baynes. (2001) Nonablative allogeneic hematopoietic stem cell transplantation. Current Opinion in Oncology 13:1, pages 27-32.
Crossref
Crossref
. (2000) Current Awareness. Hematological Oncology 18:4, pages 161-168.
Crossref
Crossref